Addenbrooke's cognitive examination-revised: normative and accuracy data for seniors with heterogeneous educational level in Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
36
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
CAMBRIDGE UNIV PRESS
Citação
INTERNATIONAL PSYCHOGERIATRICS, v.29, n.8, p.1345-1353, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background:Several cognitive tools have been developed aiming to diagnose dementia. The cognitive battery Addenbrooke's Cognitive Examination - Revised (ACE-R) has been used to detect cognitive impairment; however, there are few studies including samples with low education. The aim of the study was to provide ACE-R norms for seniors within a lower education, including illiterates. An additional aim was to examine the accuracy of the ACE-R to detect dementia and cognitive impairment no dementia (CIND). Methods:Data originated from an epidemiological study conducted in the municipality of Tremembe, Brazil. The Brazilian version of ACE-R was applied as part of the cognitive assessment in all participants. Of the 630 participants, 385 were classified as cognitively normal (CN) and were included in the normative data set, 110 individuals were diagnosed with dementia, and 135 were classified as having CIND. Results:ACE-R norms were provided with the sample stratified into age and education bands. ACE-R total scores varied significantly according to age, education, and sex. To distinguish CN from dementia, a cut-off of 64 points was established (sensitivity 91%, specificity 76%) and to differentiate CN from CIND the best cut-off was 69 points (sensitivity 73%, specificity 65%). Cut-off scores varied according to the educational level. Conclusions:This study offers normative and accuracy parameters for seniors with lower education and it should expand the use of the ACE-R for this population segment.
Palavras-chave
dementia, epidemiology, cognitive testing, screening, mild cognitive impairment
Referências
  1. Begeti F, 2013, J NEUROL, V260, P2777, DOI 10.1007/s00415-013-7061-5
  2. Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014
  3. Burton L, 2015, J REHABIL MED, V47, P193, DOI 10.2340/16501977-1930
  4. Caramelli P, 2007, ALZ DIS ASSOC DIS, V21, P65, DOI 10.1097/WAD.0b013e31802f244f
  5. Carvalho V. A., 2012, COGN BEHAV NEUROL, V25, P72, DOI [10.1097/WNN.0b013e318259594b, DOI 10.1097/WNN.0B013E318259594B]
  6. Carvalho Viviane Amaral, 2007, Dement. neuropsychol., V1, P212, DOI 10.1590/s1980-57642008dn10200015
  7. Carvalho VA, 2010, COGN BEHAV NEUROL, V23, P8, DOI 10.1097/WNN.0b013e3181c5e2e5
  8. Cesar KG, 2016, ALZ DIS ASSOC DIS, V30, P264, DOI 10.1097/WAD.0000000000000122
  9. Connick P, 2013, BEHAV NEUROL, V27, P259, DOI 10.3233/BEN-120286
  10. Fang R, 2014, DEMENT GERIATR COGN, V37, P223, DOI 10.1159/000353541
  11. FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
  12. Frota Norberto Anízio Ferreira, 2011, Dement. neuropsychol., V5, P146, DOI 10.1590/S1980-57642011DN05030002
  13. Goncalves C, 2015, AGING NEUROPSYCHOL C, V22, P473, DOI 10.1080/13825585.2014.984652
  14. Hsieh S, 2013, DEMENT GERIATR COGN, V36, P242, DOI 10.1159/000351671
  15. JORM AF, 1994, PSYCHOL MED, V24, P145
  16. Dos Santos Kawata K. H., 2012, DEMENT GERIATR COGN, V2, P29, DOI [10.1159/000336909, DOI 10.1159/000336909]
  17. Larner AJ, 2014, INT PSYCHOGERIATR, V26, P555, DOI 10.1017/S1041610213002329
  18. Mathuranath PS, 2000, NEUROLOGY, V55, P1613
  19. McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005
  20. Menon R, 2014, ANN INDIAN ACAD NEUR, V17, P420, DOI 10.4103/0972-2327.144018
  21. Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610
  22. Munoz-Neira C, 2012, REV MED CHILE, V140, P1006, DOI 10.4067/S0034-98872012000800006
  23. Neri AL, 2013, CAD SAUDE PUBLICA, V29, P778, DOI 10.1590/S0102-311X2013000400015
  24. NITRINI R, 1994, ARQ NEURO-PSIQUIAT, V52, P457
  25. Nitrini R, 2009, INT PSYCHOGERIATR, V21, P622, DOI 10.1017/S1041610209009430
  26. Perroco TR, 2009, INT PSYCHOGERIATR, V21, P531, DOI 10.1017/S1041610209008849
  27. Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237
  28. PFEFFER RI, 1982, J GERONTOL, V37, P323
  29. Pigliautile M, 2011, DEMENT GERIATR COGN, V32, P301, DOI 10.1159/000334657
  30. Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007
  31. Raimondi C, 2012, J NEUROL SCI, V322, P228, DOI 10.1016/j.jns.2012.08.002
  32. Rittman T, 2013, J NEUROL NEUROSUR PS, V84, P544, DOI 10.1136/jnnp-2012-303618
  33. Tsoi KKF, 2015, JAMA INTERN MED, V175, P1450, DOI 10.1001/jamainternmed.2015.2152
  34. Wong LL, 2013, NEUROPSYCH DIS TREAT, V9, P731, DOI 10.2147/NDT.S45477